ALNYLAM PHARMACEUTICALS, INC.

Lobbying client · Massachusetts · filed 2025 to 2026

Pharmaceutical manufacturer.

$200,000 Reported spend

8 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 8 filings. Everything on this page is grouped by the client's LDA id (64701), not by name.

Firms hired 1

CAPITOL COUNSEL LLC $200,000 8 filings

Reported by year 2 years

2026 $90,000 2 filings
2025 $110,000 6 filings

Issues lobbied 1

Medical/Disease Research/Clinical Labs 8

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

Food & Drug Administration (FDA) 6
HOUSE OF REPRESENTATIVES 2
SENATE 2

Recent filings 8 total

Q2

CAPITOL COUNSEL LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $30,000 income · posted Jul 16, 2026

View → Q1

CAPITOL COUNSEL LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $60,000 income · posted Apr 16, 2026

View → Q4

CAPITOL COUNSEL LLC

4th Quarter (Oct 1 - Dec 31) 2025 · $30,000 income · posted Jan 18, 2026

View → Q3

CAPITOL COUNSEL LLC

3rd Quarter (July 1 - Sep 30) 2025 · $30,000 income · posted Oct 15, 2025

View → Q2

CAPITOL COUNSEL LLC

2nd Quarter (Apr 1 - June 30) 2025 · $30,000 income · posted Jul 17, 2025

View → Q1

CAPITOL COUNSEL LLC

1st Quarter (Jan 1 - Mar 31) 2025 · $20,000 income · posted Apr 17, 2025

View → RA

CAPITOL COUNSEL LLC

1st Quarter (Jan 1 - Mar 31) 2025 · posted Mar 7, 2025

View → RR

CAPITOL COUNSEL LLC

1st Quarter (Jan 1 - Mar 31) 2025 · posted Mar 7, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.